Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON study

Cancer Epidemiology
E EstebanM Provencio

Abstract

The aim of the REASON study is to determine the frequency of EGFR mutation in advanced non-small cell lung cancer (aNSCLC) patients in Spain (all histologies), and to better understand the clinical factors (gender, smoking habits and histological subtypes) that may be associated with EGFR mutations, in an unselected sample of aNSCLC patients. All newly diagnosed aNSCLC patients from 40 selected centers in Spain were prospectively included for a 6-month period. Patient characteristics were obtained from clinical records. Mutation testing was performed on available tumor samples. Exploratory analyses were performed to characterize the clinico-pathological factors associated with presence of EGFR mutations. From March 2010 to March 2011, 1113 patients were included in the study, of which 1009 patients provided sample for EGFR mutation analysis (90.7%). Mutation analysis was not feasible in 146/1113 patients (13.1%) due to either sample unavailability (79/1113; 7.1%) or sample inadequacy (67/1113; 6.0%). Twenty-five out of 1113 patients (2.3%) were excluded due to unavailable information. Most patients (99.5%) were Caucasian, 74.5% were male, and predominantly were current (38.1%) or former smokers (44.0%). Median age was 66 years ...Continue Reading

References

May 19, 2005·International Journal of Cancer. Journal International Du Cancer·Susan S DevesaD Max Parkin
Feb 24, 2007·Nature Reviews. Cancer·Sreenath V SharmaDaniel A Haber
Apr 6, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Alex ChangNick Thatcher
Nov 4, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Miguel A Molina-VilaRafael Rosell
Dec 25, 2008·Expert Review of Anticancer Therapy·Toyoaki HidaKimihide Yoshida
Jun 2, 2009·Nature Reviews. Clinical Oncology·Helena LinardouSamuel Murray
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Aug 21, 2009·The New England Journal of Medicine·Rafael RosellUNKNOWN Spanish Lung Cancer Group
Aug 28, 2009·European Journal of Cancer Care·J M García PrimL Valdés Cuadrado
Jun 25, 2010·The New England Journal of Medicine·Makoto MaemondoUNKNOWN North-East Japan Study Group
Oct 23, 2010·Nature Reviews. Cancer·William Pao, Juliann Chmielecki
Nov 26, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·J Matthew ReinersmanMark G Kris
Jan 27, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Natasha RekhtmanAndre L Moreira
Mar 15, 2011·Cancer Cytopathology·Gilda da Cunha SantosNatasha Leighl
May 14, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Geoffrey Y KuGilberto de Lima Lopes
Oct 19, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Oscar ArrietaUNKNOWN CLICaP
Jan 31, 2012·The Lancet Oncology·Rafael RosellUNKNOWN Spanish Lung Cancer Group in collaboration with Groupe Français de Pneumo-Cancérologie and Associazione Italiana Oncologia T
Mar 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ji-Youn HanJin Soo Lee
Apr 3, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sébastien CouraudPierre-Jean Souquet
Nov 29, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M Beau-FallerJ Cadranel
Jan 7, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Britta WeberPeter Meldgaard

❮ Previous
Next ❯

Citations

Jan 15, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ibrahim ElghissassiHassan Errihani
Apr 7, 2018·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·E ArriolaG López-Vivanco
Oct 17, 2019·PloS One·Julien P L VincentenErik Thunnissen
Jul 1, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J RemonE Felip
Sep 4, 2019·Journal of Comparative Effectiveness Research·Javier Aguilar-SerraJulio Cortijo
Oct 31, 2020·Current Opinion in Oncology·Lingyun YeFei Zhou
Nov 14, 2020·Translational Oncology·Gad RennertNaomi Gronich
Feb 27, 2021·Journal of Comparative Effectiveness Research·Javier Aguilar-SerraJulio Cortijo
Jul 24, 2018·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Iikki DonnerLauri A Aaltonen
Oct 5, 2021·Expert Review of Pharmacoeconomics & Outcomes Research·J Aguilar-SerraJ Cortijo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.